{
    "2018-09-26": [
        [
            {
                "time": "",
                "original_text": "重慶接种全國首劑五價輪狀疫苗 智飛生物獨家代理四年",
                "features": {
                    "keywords": [
                        "重慶",
                        "五價輪狀疫苗",
                        "智飛生物",
                        "獨家代理"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "醫療保健",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "A股已成香饽饽！6張圖看外資在股、債之間大輪動",
                "features": {
                    "keywords": [
                        "A股",
                        "外資",
                        "股債輪動"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "股票市場",
                        "債券市場"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "看好中國｜健康中國——估值較低 市場反彈之際關注龍頭標的",
                "features": {
                    "keywords": [
                        "健康中國",
                        "估值較低",
                        "龍頭標的"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "醫療保健",
                        "消費升級"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "醫療保健：完善國家基藥制度 仿製藥加速優勝劣汰",
                "features": {
                    "keywords": [
                        "醫療保健",
                        "國家基藥制度",
                        "仿製藥",
                        "優勝劣汰"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "醫療保健",
                        "藥品製造"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}